|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM298388537 |
| 003 |
DE-627 |
| 005 |
20231225094039.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.201901081
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0994.xml
|
| 035 |
|
|
|a (DE-627)NLM298388537
|
| 035 |
|
|
|a (NLM)31222852
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Vaughan, Hannah J
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 30.12.2020
|
| 500 |
|
|
|a Date Revised 12.11.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
| 520 |
|
|
|a Nucleic acids are a promising type of therapeutic for the treatment of a wide range of conditions, including cancer, but they also pose many delivery challenges. For efficient and safe delivery to cancer cells, nucleic acids must generally be packaged into a vehicle, such as a nanoparticle, that will allow them to be taken up by the target cells and then released in the appropriate cellular compartment to function. As with other types of therapeutics, delivery vehicles for nucleic acids must also be designed to avoid unwanted side effects; thus, the ability of such carriers to target their cargo to cancer cells is crucial. Classes of nucleic acids, hurdles that must be overcome for effective intracellular delivery, types of nonviral nanomaterials used as delivery vehicles, and the different strategies that can be employed to target nucleic acid delivery specifically to tumor cells are discussed. Additonally, nanoparticle designs that facilitate multiplexed delivery of combinations of nucleic acids are reviewed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a cancer therapy
|
| 650 |
|
4 |
|a gene delivery
|
| 650 |
|
4 |
|a nanoparticles
|
| 650 |
|
4 |
|a nucleic acid
|
| 650 |
|
4 |
|a targeted delivery
|
| 650 |
|
7 |
|a Nucleic Acids
|2 NLM
|
| 700 |
1 |
|
|a Green, Jordan J
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tzeng, Stephany Y
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 32(2020), 13 vom: 21. Apr., Seite e1901081
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:32
|g year:2020
|g number:13
|g day:21
|g month:04
|g pages:e1901081
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201901081
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 32
|j 2020
|e 13
|b 21
|c 04
|h e1901081
|